Carlos Camero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carlos Camero has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Rojas
Department of Genetics University of Cordoba Cordoba Spain
4 shared publications - Camila Bernal
Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Carrera 7 No. 40-62, Edificio 32, Bogotá 110231, Colombia
4 shared publications - Alejandra Cañas
Departamento de Medicina Interna, School of Medicine, Pontificia Universidad Javeriana, Carrera 7 No. 40-62, 2.Ed. Fernando Barón, Bogotá 110231, Colombia
2 shared publications - Daniel Mauricio González
Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Carrera 7 No. 40-62, Edificio 32, Bogotá 110231, Colombia
2 shared publications - Litzy Gisella Bermúdez
Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Carrera 7 No. 40-62, Edificio 32, Bogotá 110231, Colombia
2 shared publications - Nicolás Niederbacher
Epigenetics and Cancer Research Group, Institute of Human Genetics, Pontificia Universidad Javeriana, Bogotá 110231, Colombia
2 shared publications
Latest Publications
- Open Access
- 11 June 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 301, 118485
Analysis of the transcriptional profile of mononuclear cells from e-cigarette users
- 11 June 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 301, 118485
Open AccessAnalysis of the transcriptional profile of mononuclear cells from e-cigarette users
- Open Access
- 11 April 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 256, 114900
Genotoxicity and hypomethylation of LINE-1 induced by electronic cigarettes
- 11 April 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 256, 114900
Open AccessGenotoxicity and hypomethylation of LINE-1 induced by electronic cigarettes
- Open Access
- 19 January 2021
- Published by Spandidos Publications
- Vol. 1 (1) , 1
Electronic cigarettes: Genetic and epigenetic impact (Review)
Electronic cigarettes (ECIGs) are electronic devices that heat and vaporize a solution that usually contains a mixture of glycerol, propylene glycol, water, flavors and various concentrations of nicotine. ECIGs have 3 key components: A power source, a cartridge containing an atomizer along with a liquid solution and a mouthpiece. The solution (often known as e‑liquid or e‑juice) is heated into an aerosol inhaled by the user. Smoking conventional cigarettes is considered a determinant factor in the development of chronic respiratory diseases, cardiovascular diseases, cancers, and reproductive system dysfunctions. Conventional smoking also causes genome damage and alteration of the transcriptome, due to the amounts of noxious substances emitted during the combustion of these products. Recently, cigarette consumers have begun to use ECIGs as a replacement or substitute practice to help them quit smoking. In addition, an increase in the use of ECIGs and similar devices by young individuals has been reported, which is unsurprising due to the unregulated distribution and sale of these products. The present review article describes and discusses the impact and the noxious effects of substances in ECIGs and other nicotine administration systems on DNA structure, gene expression profile, and epigenetic modification, focusing on the respiratory system and embryonic development.
- 19 January 2021
- Published by Spandidos Publications
- Vol. 1 (1) , 1
Open AccessElectronic cigarettes: Genetic and epigenetic impact (Review)
Electronic cigarettes (ECIGs) are electronic devices that heat and vaporize a solution that usually contains a mixture of glycerol, propylene glycol, water, flavors and various concentrations of nicotine. ECIGs have 3 key components: A power source, a cartridge containing an atomizer along with a liquid solution and a mouthpiece. The solution (often known as e‑liquid or e‑juice) is heated into an aerosol inhaled by the user. Smoking conventional cigarettes is considered a determinant factor in the development of chronic respiratory diseases, cardiovascular diseases, cancers, and reproductive system dysfunctions. Conventional smoking also causes genome damage and alteration of the transcriptome, due to the amounts of noxious substances emitted during the combustion of these products. Recently, cigarette consumers have begun to use ECIGs as a replacement or substitute practice to help them quit smoking. In addition, an increase in the use of ECIGs and similar devices by young individuals has been reported, which is unsurprising due to the unregulated distribution and sale of these products. The present review article describes and discusses the impact and the noxious effects of substances in ECIGs and other nicotine administration systems on DNA structure, gene expression profile, and epigenetic modification, focusing on the respiratory system and embryonic development.
- 16 December 2019
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 61 (1)
Control epigenético en la transición epiteliomesénquima
- 16 December 2019
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 61 (1)
Control epigenético en la transición epiteliomesénquima